A

AcuraStem

12 employees

AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.

Basic info

Industry

biotechnology research

Sectors

Health Diagnostics
Biotechnology
Neuroscience
Health Care
Artificial Intelligence
Therapeutics
Medical

Date founded

2016

Funding rounds raised

Total raised

$1M

from 2 investors over 2 rounds

A

AcuraStem raised $1M on November 8, 2019

Investors: Viva Biotech (Shanghai) Ltd. and Keiretsu Forum / Capital

FAQ